Lymphoma, T-Cell, Peripheral
Showing 1 - 20 of 20
Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)
Recruiting
- Lymphoma, T-Cell, Peripheral
- +4 more
- MT-101
- MT-101 + Conditioning (Lymphodepleting) Chemotherapy
-
Duarte, California
- +8 more
Jan 27, 2023
Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma
Recruiting
- Lymphoma, T-cell, Peripheral
- Lymphoma, T-cell, Cutaneous
-
Nagoya, Japan
- +2 more
Nov 24, 2022
Lymphoma, T-Cell, Peripheral Trial in Czechia (Adcetris 50 MG Injection, Endoxan, Doxorubicin)
Not yet recruiting
- Lymphoma, T-Cell, Peripheral
- Adcetris 50 MG Injection
- +4 more
-
Brno, Czechia
- +6 more
Aug 26, 2021
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)
Terminated
- Lymphoma, T-Cell, Cutaneous
- +6 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Jan 20, 2021
Lymphoma, T-Cell, Peripheral Trial in United States (Romidepsin, Ixazomib)
Active, not recruiting
- Lymphoma, T-Cell, Peripheral
-
Chicago, Illinois
- +6 more
Jan 15, 2021
Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Hodgkin Disease Trial in Chicago, Saint Louis (Romidepsin,
Completed
- Lymphoma, T-Cell, Cutaneous
- +3 more
- Romidepsin
- +4 more
-
Chicago, Illinois
- +1 more
Nov 16, 2020
Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral Trial in Canada, United States (Nilotinib)
Completed
- Bone Marrow Transplant Failure
- +2 more
-
Stanford, California
- +4 more
Apr 13, 2020
Prospective Collection of Data in Peripheral T-Cell Lymphoma
Completed
- Lymphoma, T-Cell, Peripheral
-
Palo Alto, California
- +75 more
Jul 3, 2019
Lymphoma, T-Cell, Peripheral Trial in Worldwide (CHOP14 chemo (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison)
Completed
- Lymphoma, T-Cell, Peripheral
- CHOP14 chemotherapy (cyclophosphamide, hydroxydaunorubicin, vincristin, prednison) plus G-CSF, combined with alemtuzumab
- CHOP14 chemotherapy (see specification under Arm B) plus G-CSF
-
Linz, Austria
- +58 more
Feb 27, 2019
Lymphoma, T-cell, Peripheral Trial in Japan (Romidepsin)
Completed
- Lymphoma, T-cell, Peripheral
-
Nagoya, Aichi, Japan
- +16 more
Jan 28, 2019
Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell
Completed
- Lymphoma, T-Cell, Peripheral
- No Intervention
-
Santiago de Compostela, A Coruna, Spain
- +9 more
Mar 17, 2017
Lymphoma, T-Cell, Peripheral Trial in Beijing (18F-FDG PET/CT)
Unknown status
- Lymphoma, T-Cell, Peripheral
- 18F-FDG PET/CT
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Feb 9, 2017
Lymphoma, T-Cell, Peripheral Trial in Beijing (18F-FDG PET/ CT)
Unknown status
- Lymphoma, T-Cell, Peripheral
- 18F-FDG PET/ CT
-
Beijing, Beijing, ChinaPeking University Cancer Hospital
Feb 9, 2017
Lymphoma, T-Cell, Peripheral Trial in Beijing (GDP chemo)
Unknown status
- Lymphoma, T-Cell, Peripheral
- GDP chemotherapy
-
Beijing, Beijing, ChinaCancer Hospital and Institute, Chinese Academy of Medical Scienc
Jul 25, 2016
Lymphoma, T-Cell, Peripheral, Febrile Neutropenia Trial in Korea, Republic of
Unknown status
- Lymphoma, T-Cell, Peripheral
- Febrile Neutropenia
-
Cheonan, Korea, Republic of
- +17 more
Feb 10, 2015
Acute Myeloid Leukemia, Myelodysplasia, Acute Lymphoblastic Leukemia Trial in San Francisco (umbilical cord stem cells)
Terminated
- Acute Myeloid Leukemia
- +9 more
- umbilical cord stem cells
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 13, 2013
Lymphoma, T-Cell, Peripheral Trial in Italy (Clin A. CHOP-CAMPATH (Chemo-immunotherapy) + SCT, Clin B (CHOP- CAMPATH)
Completed
- Lymphoma, T-Cell, Peripheral
- Clin A. CHOP-CAMPATH (Chemo-immunotherapy) + SCT
- Clin B (CHOP- CAMPATH) Chemo-immunotherapy
-
Orbassano, Torino, Italy
- +16 more
Sep 3, 2012